Table 1 Demographic and clinical parameters of patients with cystic fibrosis (CF) and healthy subjects (controls).

From: Oxylipin profile in saliva from patients with cystic fibrosis reveals a balance between pro-resolving and pro-inflammatory molecules

 

CF patients (n = 69)

Controls (n = 50)

P value

Age (years)

30 (22–40)

33 (29–41)

n.s

Males, n (%)

37 (53.6)

18 (36)

n.s

Lung disease severity, n (%):

   

Severe a

7 (10.2)

-

 

Moderate b

21 (30.4)

-

 

Mild c

41 (59.4)

-

 

Pancreatic insufficiency, n (%)

37 (53.6)

-

 

PA colonization, n (%)

34 (49.3)

-

 

ITH, n (%)

10 (14.5)

-

 

NP, n (%)

9 (13.0)

-

 
  1. a FEV1 < 40%; b FEV1 40–69%; c FEV1 > 69%. ITH: inferior turbinate hypertrophy; NP: nasal polyposis; n.s.: not significant; PA: P. aeruginosa.
Back to article page